References
- de los Santos ET, Mazzaferri EL. Thyroid function tests: guidelines for interpretation in common clinical disorders. Postgrad Med 1989: 85(5): 333–52
- de los Santos ET, Stanch GH, Mazzaferri EL. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatoiy patients. Arch Intern Med 1989: 149(3): 526–32
- de los Santos ET, Mazzaferri EL. Sensitive thyroid-stimulating hormone assays: clinical applications and limitations. Compr Ther 1988: 14(9): 26–33
- Ingbar SH. Thyrotoxicosis: classification and manifestations. In: Ingbar SH, Braverman LE, eds. Werner's the thyroid: a fundamental and clinical text. 5 th ed. Philadelphia: JB Lippincott, 1986: 809–10
- Rajatanavin R, Chailurkit LO, Srisupandit S, et al. Trophoblastic hyperthyroidism: clinical and biochemical features of five cases. Am J Med 1988: 85(2): 237–41
- Cooper DS. Antithyroid drugs. N Engl J Med 1984: 311 (21): 1353–62
- Ledere J. Antithyroid drugs: a rational treatment for Graves' disease? Horm Resl 1987: 26(M): 125–30
- Hanson JS. Propylthiouracil and hepatitis: two cases and a review of the literature. Arch Intern Med 1984: 144(5): 994–6
- Mazzaferri EL, Reynolds JC, Young RL, et al. Propranolol as primary therapy for thyrotoxicosis. Arch Intern Med 1976: 136(1): 50–6
- Feely J, Peden N. Use of beta-adrenoceptor blocking drugs in hyperthyroidism. Drugs 1984: 27(5): 425–46
- Rubin PC. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981: 305(22): 1323–6
- Braverman LE. Iodide-induced thyroid disease. In: Ingbar, Braverman, eds,4 pp 735–46
- Orgiazzi J. Management of Graves' hyperthyroidism. Endocrinol Metab Clin North Am 1987: 16(2): 365–89
- Kamel N, Uysal AR, Kologlu S, et al. Sodium ipodate in the treatment of toxic diffuse goiten short-term and long-term effects on thyrotoxicosis. Endocrinologie 1988: 26(2): 99–105
- Chang DC, Wheeler MH, Woodcock JP, et al. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery 1987: 102(6): 1055–61
- Goolden AW, Stewart JS. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1986: 24(2): 217–22
- Graham GD, Burman KD. Radioiodine treatment of Graves' disease: an assessment of its potential risks. Ann Intern Med 1986: 105(6): 900–5
- Harada T, Shimaoka K, Mimura T, et al. Current treatment of Graves' disease. Surg Clin North Am 1987: 67(2): 299–314
- Wartofsky L. Management of hyperthyroidism due to Graves' disease. Proceedings of Endocrine Society, 71st Annual Meeting. Seattle: American Thyroid Assn, 1989 Jun: 21
- Mazzaferri E. Graves' disease and thyroid carcinoma. (Editorial) J Clin Endocrinol Metab (in press)